Aikaterini Liapi
Overview
Explore the profile of Aikaterini Liapi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liapi A, Silva S, Folia V
Eur J Investig Health Psychol Educ
. 2024 Mar;
14(3):699-708.
PMID: 38534907
While the link between beat perception and reading skills is attributed to a general improvement in neural entrainment to speech units, duration perception (DP) is primarily linked to a specific...
2.
Jankovic J, Abdelhamid K, Berthold D, Desbaillets N, Bouchaab H, Dei Tos G, et al.
Rev Med Suisse
. 2024 Jan;
20(856-7):80-87.
PMID: 38231107
The oncology field continues its remarkable evolution over the years, with promising advances leading to innovative and individualized treatments. The development of new molecules, the identification of new therapeutic targets...
3.
Liapi A, Atat C, Dunet V, Sarivalasis A
SAGE Open Med Case Rep
. 2023 May;
11:2050313X231176401.
PMID: 37250819
Posterior reversible encephalopathy syndrome is a rare neurological disorder, the diagnosis of which is based on the combination of clinical and radiological findings. It can be associated with many patient-related...
4.
Giacomuzzi Moore B, Liapi A, Dolcan A, Kakourou A, Masmoudi S, Latifyan S, et al.
Rev Med Suisse
. 2023 May;
19(827):944-949.
PMID: 37195107
Frequent and with an increasing incidence in some territories, endometrial cancer is a complex disease leading to significant morbidity among affected patients. After years of research and the implementation of...
5.
Wetterwald L, Sarivalasis A, Liapi A, Mathevet P, Achtari C
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765848
Borderline ovarian tumors (BOTs) account for 10-20% of epithelial ovarian neoplasms. They are characterized by their lack of destructive stromal invasion. In comparison to invasive ovarian cancers, BOTs occur in...
6.
Herrera Gomez R, Hastir D, Liapi A, Dolcan A, Herrera F, Mathevet P, et al.
Case Rep Oncol
. 2022 Feb;
14(3):1792-1798.
PMID: 35111011
Serous carcinoma of the uterine cervix (SCUC) is now believed to be a morphological variant of an HPV-associated endocervical adenocarcinoma or a metastasis from a serous carcinoma of the upper...
7.
Bandiera C, Cardoso E, Locatelli I, Digklia A, Zaman K, Diciolla A, et al.
JMIR Res Protoc
. 2021 Jun;
10(6):e30090.
PMID: 34185020
Background: The strengthening or substitution of intravenous cytotoxic chemotherapy cycles by oral targeted anticancer therapies, such as protein kinase inhibitors (PKIs), has provided impressive clinical benefits and autonomy as well...
8.
Liapi A, Mathevet P, Herrera F, Hastir D, Sarivalasis A
Front Oncol
. 2021 Apr;
11:641376.
PMID: 33842348
Uterine perivascular epithelioid cell tumors (PEComas) are rare neoplasms. PI3K/AKT/mTOR pathway upregulation is critical for their pathogenesis and is often associated with TSC1/TSC2 inactivation. Although first line mTOR inhibitors are...
9.
Kopetti C, Schaffer C, Zaman K, Liapi A, di Summa P, Bauquis O
Clin Breast Cancer
. 2020 Dec;
21(3):e154-e157.
PMID: 33341378
No abstract available.
10.
Liapi A, Sarivalasis A
Case Rep Oncol
. 2020 Oct;
13(2):1006-1012.
PMID: 32999664
The reported case is a 61-year-old woman, admitted for gradual onset of gait disturbances and dysphonia. The serum immunological panel revealed anti-Yo autoantibodies, suggestive of a paraneoplastic syndrome (PNS). A...